The results showed that compared with insulin glargine, Tirzepatide showed better HbA1c and weight reduction in the population of type 2 diabetes patients in the Asia-Pacific region (mainly China): HbA1c reduction of up to 2.49% and weight reduction of up to 7.2 kg (9.4%) at 40 weeks of treatment, significant improvement in blood lipids and blood pressure, and overall safety and tolerability were good
A drugadverse-event combination that met the criteria of all four indices was deemed a signal
Brain fog linked to mold or toxin exposure, neuroinflammation, mood imbalance, circadian disruption, cognitive impairment What if your medical team actually helped you live a longer, healthier life
Tips to Never Miss a GLP-1 Dose A missed GLP-1 dose isnt a death sentence
Individual Response Variation Not everyone responds the same way to any weight loss medication
doi: 10.1038/nm.1927 79 SaenzBPerezHJChavarriaA